Development of cell-based quantitative evaluation method for cell cycle-arrest type cancer drugs for apoptosis by high precision surface plasmon resonance sensor

Toshihiro Ona, Hiroshi Nishijima, Atsushi Kosaihira, Junko Shibata

Research output: Chapter in Book/Report/Conference proceedingConference contribution

2 Citations (Scopus)

Abstract

In vitro rapid and quantitative cell-based assay is demanded to verify the efficacy prediction of cancer drugs since a cancer patient may have unconventional aspects of tumor development. Here, we show the rapid and non-label quantitative verifying method and instrumentation of apoptosis for cell cycle-arrest type cancer drugs (Roscovitine and D-allose) by reaction analysis of living liver cancer cells cultured on a sensor chip with a newly developed high precision (50 ndeg s-1 average fluctuation) surface plasmon resonance (SPR) sensor. The time-course cell reaction as the SPR angle change rate for 10 min from 30 min cell culture with a drug was significantly related to cell viability. By the simultaneous detection of differential SPR angle change and fluorescence by specific probes using the new instrument, the SPR angle was related to the nano-order potential decrease in inner mitochondrial membrane potential. The results obtained are universally valid for the cell cycle-arrest type cancer drugs, which mediate apoptosis through different cell-signaling pathways, by a liver cancer cell line of Hep G2 (P≤0.001). This system towards the application to evaluate personal therapeutic potentials of drugs using cancer cells from patients in clinical use.

Original languageEnglish
Title of host publicationBiophotonics
Subtitle of host publicationPhotonic Solutions for Better Health Care
Volume6991
DOIs
Publication statusPublished - Jun 18 2008
EventBiophotonics: Photonic Solutions for Better Health Care - Strasbourg, France
Duration: Apr 8 2008Apr 10 2008

Other

OtherBiophotonics: Photonic Solutions for Better Health Care
CountryFrance
CityStrasbourg
Period4/8/084/10/08

Fingerprint

Surface plasmon resonance
Cell death
Cells
Sensors
Liver
Cell signaling
Cell culture
Tumors
Assays
Fluorescence
Membranes

All Science Journal Classification (ASJC) codes

  • Engineering(all)

Cite this

Ona, T., Nishijima, H., Kosaihira, A., & Shibata, J. (2008). Development of cell-based quantitative evaluation method for cell cycle-arrest type cancer drugs for apoptosis by high precision surface plasmon resonance sensor. In Biophotonics: Photonic Solutions for Better Health Care (Vol. 6991). [69910R] https://doi.org/10.1117/12.780819

Development of cell-based quantitative evaluation method for cell cycle-arrest type cancer drugs for apoptosis by high precision surface plasmon resonance sensor. / Ona, Toshihiro; Nishijima, Hiroshi; Kosaihira, Atsushi; Shibata, Junko.

Biophotonics: Photonic Solutions for Better Health Care. Vol. 6991 2008. 69910R.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Ona, T, Nishijima, H, Kosaihira, A & Shibata, J 2008, Development of cell-based quantitative evaluation method for cell cycle-arrest type cancer drugs for apoptosis by high precision surface plasmon resonance sensor. in Biophotonics: Photonic Solutions for Better Health Care. vol. 6991, 69910R, Biophotonics: Photonic Solutions for Better Health Care, Strasbourg, France, 4/8/08. https://doi.org/10.1117/12.780819
Ona, Toshihiro ; Nishijima, Hiroshi ; Kosaihira, Atsushi ; Shibata, Junko. / Development of cell-based quantitative evaluation method for cell cycle-arrest type cancer drugs for apoptosis by high precision surface plasmon resonance sensor. Biophotonics: Photonic Solutions for Better Health Care. Vol. 6991 2008.
@inproceedings{31f83d9061204d58abac008186803926,
title = "Development of cell-based quantitative evaluation method for cell cycle-arrest type cancer drugs for apoptosis by high precision surface plasmon resonance sensor",
abstract = "In vitro rapid and quantitative cell-based assay is demanded to verify the efficacy prediction of cancer drugs since a cancer patient may have unconventional aspects of tumor development. Here, we show the rapid and non-label quantitative verifying method and instrumentation of apoptosis for cell cycle-arrest type cancer drugs (Roscovitine and D-allose) by reaction analysis of living liver cancer cells cultured on a sensor chip with a newly developed high precision (50 ndeg s-1 average fluctuation) surface plasmon resonance (SPR) sensor. The time-course cell reaction as the SPR angle change rate for 10 min from 30 min cell culture with a drug was significantly related to cell viability. By the simultaneous detection of differential SPR angle change and fluorescence by specific probes using the new instrument, the SPR angle was related to the nano-order potential decrease in inner mitochondrial membrane potential. The results obtained are universally valid for the cell cycle-arrest type cancer drugs, which mediate apoptosis through different cell-signaling pathways, by a liver cancer cell line of Hep G2 (P≤0.001). This system towards the application to evaluate personal therapeutic potentials of drugs using cancer cells from patients in clinical use.",
author = "Toshihiro Ona and Hiroshi Nishijima and Atsushi Kosaihira and Junko Shibata",
year = "2008",
month = "6",
day = "18",
doi = "10.1117/12.780819",
language = "English",
isbn = "9780819471895",
volume = "6991",
booktitle = "Biophotonics",

}

TY - GEN

T1 - Development of cell-based quantitative evaluation method for cell cycle-arrest type cancer drugs for apoptosis by high precision surface plasmon resonance sensor

AU - Ona, Toshihiro

AU - Nishijima, Hiroshi

AU - Kosaihira, Atsushi

AU - Shibata, Junko

PY - 2008/6/18

Y1 - 2008/6/18

N2 - In vitro rapid and quantitative cell-based assay is demanded to verify the efficacy prediction of cancer drugs since a cancer patient may have unconventional aspects of tumor development. Here, we show the rapid and non-label quantitative verifying method and instrumentation of apoptosis for cell cycle-arrest type cancer drugs (Roscovitine and D-allose) by reaction analysis of living liver cancer cells cultured on a sensor chip with a newly developed high precision (50 ndeg s-1 average fluctuation) surface plasmon resonance (SPR) sensor. The time-course cell reaction as the SPR angle change rate for 10 min from 30 min cell culture with a drug was significantly related to cell viability. By the simultaneous detection of differential SPR angle change and fluorescence by specific probes using the new instrument, the SPR angle was related to the nano-order potential decrease in inner mitochondrial membrane potential. The results obtained are universally valid for the cell cycle-arrest type cancer drugs, which mediate apoptosis through different cell-signaling pathways, by a liver cancer cell line of Hep G2 (P≤0.001). This system towards the application to evaluate personal therapeutic potentials of drugs using cancer cells from patients in clinical use.

AB - In vitro rapid and quantitative cell-based assay is demanded to verify the efficacy prediction of cancer drugs since a cancer patient may have unconventional aspects of tumor development. Here, we show the rapid and non-label quantitative verifying method and instrumentation of apoptosis for cell cycle-arrest type cancer drugs (Roscovitine and D-allose) by reaction analysis of living liver cancer cells cultured on a sensor chip with a newly developed high precision (50 ndeg s-1 average fluctuation) surface plasmon resonance (SPR) sensor. The time-course cell reaction as the SPR angle change rate for 10 min from 30 min cell culture with a drug was significantly related to cell viability. By the simultaneous detection of differential SPR angle change and fluorescence by specific probes using the new instrument, the SPR angle was related to the nano-order potential decrease in inner mitochondrial membrane potential. The results obtained are universally valid for the cell cycle-arrest type cancer drugs, which mediate apoptosis through different cell-signaling pathways, by a liver cancer cell line of Hep G2 (P≤0.001). This system towards the application to evaluate personal therapeutic potentials of drugs using cancer cells from patients in clinical use.

UR - http://www.scopus.com/inward/record.url?scp=44949254123&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44949254123&partnerID=8YFLogxK

U2 - 10.1117/12.780819

DO - 10.1117/12.780819

M3 - Conference contribution

SN - 9780819471895

VL - 6991

BT - Biophotonics

ER -